Shinva Medical Instrument announced that the company has decided to acquire 36.19% equity in Wuhan Zhongzhi Biotechnology Co., Ltd. This acquisition aims to expand the company's business layout in the field of biotechnology, further enhancing the company's market competitiveness and business diversification capability.
- Latest
- Detail
新华医疗：收购武汉中帜36.19%股权
Shinva Medical Instrument: Acquisition of 36.19% equity in Wuhan Zhongzhi.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Write a comment
0 0 0
LikeLoveLaughing CryRespectEmmSadAngry
Tap to Select a Mood
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
Use the share button in your browser
to share the page with your friends
Tap here to share
No comments yet. Write one.
Related Stocks Related Stocks
Latest
19:36
Trump is considering declaring a national economic emergency to allow for a new tariff plan.
19:36
Futures for the S&P 500 Index and NASDAQ 100 Index quickly turned lower.
.SPX-1.11%
19:35
Air Lease: As of December 31, 269 new aircraft have been ordered from Airbus and Boeing, with expected deliveries until 2029.
BA+1.01%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.